News
The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.
The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and its ...
HCA Healthcare raises 2025 profit forecast amidst insurance uncertainty while Centene anticipates a 2026 profitability boost ...
10hon MSN
Notable healthcare headlines for the week: Pfizer, UnitedHealth, Sarepta and Thermo Fisher in focus
Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...
6h
TipRanks on MSNSarepta says eight-year-old death deemed unrelated to Elevidys
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results